Objective: To assess the radiation dose reduction during uterine artery embolization utilizing dose reduction technology.
Methods: A total of 58 women underwent uterine artery embolization. A total of 26 procedures were performed in a standard fluoroscopy suite; 32 procedures were performed utilizing a novel imaging platform. Radiation dose data and acquisition parameters were compared.
Results: The new platform provided significant reduction in the median radiation dose (P<.001): from 389Gy cm(2) to 145Gy cm(2). There were no differences between the groups with regard to acquisition parameters.
Conclusion: The new imaging platform provided a 61% dose reduction during uterine artery embolization without a significant change in acquisition parameters.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1016/j.clinimag.2015.11.012 | DOI Listing |
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!